Publisher
Springer Science and Business Media LLC
Reference22 articles.
1. FDA. Title 21 Code of Federal Regulations (CFR) 320.24. https://www.ecfr.gov/current/title-21/section-320.24. Accessed 22 Dec 2023.
2. Ring A, Lang B, Kazaroho C, Labes D, Schall R, Schütz H. Sample size determination in bioequivalence studies using statistical assurance. Br J Clin Pharmacol. 2019;85(10):2369–77.
3. Li S. Pharmacodynamic bioequivalence testing. J Clin Pharm Ther. 2012;37(5):497–8.
4. Xu SM, Xu YY, Yan J, Zhang YF, Li D, Li D, et al. Method for evaluating the human bioequivalence of acarbose based on pharmacodynamic parameters. J Int Med Res. 2020;48(10):300060520960317.
5. FDA. Guidance for Industry: Bioequivalence Guidance. https://www.fda.gov/media/70115/download. Accessed 26 Dec 2023.